Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Multiple Sclerosis Therapeutic Market

Multiple Sclerosis Therapeutic Market Share

Report ID: GMI11109
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Multiple Sclerosis Therapeutic Market Share

The multiple sclerosis therapeutic industry is marked by intense competition, with both major global companies and smaller to medium-sized firms competing for market leadership. A key aspect of market strategy involves the regular introduction of innovative therapies leveraging diverse technologies. Leading industry players significantly drive innovation through substantial investments in research and development. Additionally, strategic partnerships, acquisitions, and mergers are essential for consolidating market positions and expanding international reach.

Multiple Sclerosis Therapeutic Market Companies

Some of the eminent market participants operating in the multiple sclerosis therapeutic industry include:

Abbvie Inc.
Amgen Inc.
Acorda Therapeutics, Inc.
Biogen Inc.
Bayer AG
Bristol-Myers Squibb Company.
F. Hoffman-La Roche Ltd
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceuticals Company Limited.
Pfizer Inc.
Sanofi
Viatris Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global multiple sclerosis therapeutic industry was valued at USD 25.5 billion in 2023 and is anticipated to register 4.7% CAGR between 2024 and 2032, driven by increasing prevalence of multiple sclerosis.

The hospital pharmacy segment in the market accounted for USD 13.6 billion in 2023 due to specialized multiple sclerosis treatment, collaboration with healthcare professionals, and access to the latest therapies.

U.S. multiple sclerosis therapeutic market is expected to reach USD 13.3 billion by 2032, due to the high prevalence of multiple sclerosis and advanced healthcare facilities offering innovative treatments.

Abbvie Inc., Amgen Inc., Acorda Therapeutics, Inc., Biogen Inc., Bayer AG, Bristol-Myers Squibb Company., F. Hoffman-La Roche Ltd, and Johnson & Johnson, among others.